Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Upadacitinib after pigment-cell transplant for vitiligo
Official title: Efficacy of Upadacitinib After Autologous Non-cultured Epidermal Cell Suspension Transplantation in Vitiligo Participants -- a Pilot, Random, Observer Blinded, Comparative Study
Status: Recruiting now
Description:
Jilin University plans to enroll about 60 participants. Upadacitinib is an oral JAK inhibitor that reduces inflammatory immune signaling. Researchers hope it will slow melanocyte destruction and improve repigmentation, alone or after cell transplantation. Upadacitinib is sold as Rinvoq and is approved for atopic dermatitis and several other inflammatory conditions; vitiligo would be a new use. Possible effects include infections, acne, nausea, and headache; serious risks can include blood clots and major cardiovascular events. People ages 18 to 60 may qualify. The study is recruiting at one listed site in China.
Start date: December 04, 2024
Completion date: June 01, 2029
Organizer: Jilin University
Contact: Bing Han
Tel.: +86 159 4307 3198
Email: pfk_hanbing@jlu.edu.cn
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- Is there a special diet for vitiligo?
Recent research highlights the potential of diet and nutrition in managing vitiligo, offering an alternative where traditional therapies may be lacking. However, the relationshi...
- Is vitiligo contagious?
Vitiligo is not contagious. This means it cannot be spread from person to person through physical contact, sharing personal items, or any other means of transmission. Vitiligo i...
- Can chemicals cause vitiligo?
Certain chemicals can trigger vitiligo, leading to a condition known as chemical-induced vitiligo. While clinically and histologically indistinguishable from other types of viti...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.